Signal Transduction and Targeted Therapy (Aug 2022)

Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice

  • Fei Xue,
  • Jing Cheng,
  • Yanping Liu,
  • Cheng Cheng,
  • Meng Zhang,
  • Wenhai Sui,
  • Wenqiang Chen,
  • Panpan Hao,
  • Yun Zhang,
  • Cheng Zhang

DOI
https://doi.org/10.1038/s41392-022-01054-3
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 16

Abstract

Read online

Proposed mechanisms underlying the salutary effects of ADAM17 deficiency on diabetic cardiomyopathy. ADAM17 deficiency increases autophagosome formation and improves autophagic flux via reducing ACE2 shedding, activating AMPK pathway, and promoting TFEB nuclear translocation, which reduces the apoptotic response in cardiomyocytes and attenuates left ventricular remodeling and dysfunction in DCM of mice.